RFP Entries in Oncology Therapeutic Area

Investigator Initiated Study- Non-small cell lung cancer (NSCLC)
USA Oncology Research Study
View Full Details
Investigator-Initiated study – Pre-clinical studies with KRAS G12D
USA Oncology Research Study
View Full Details
Investigator Initiated Studies – ER+ Breast Cancer with Imlunestrant
USA Oncology Imlunestrant  Research Study
View Full Details
Investigator Initiated Trial: Colorectal Cancer with Fruquintinib
China Oncology Research Study
View Full Details
Folate Receptor Alpha (FRα) – LY4170156
USA Oncology Research Study
View Full Details
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitor – LY3866288
USA Oncology Vepugratinib Research Study
View Full Details
B-cell Activation Factor Receptor (BAFF-R) – LY4152199
USA Oncology Research Study
View Full Details
Abemaciclib (Verzenio) – LY2835219
USA Oncology Research Study
View Full Details
Medical Education Grant – Prostate Cancer
USA Oncology Medical Education
View Full Details
Medical Education Grant: Bladder Cancer
USA Oncology Medical Education
View Full Details